Skip to content

Public FDA record

Z-0929-06: Anestar and Anestar Plus Anesthesia System.

Recall record Z-0929-06 for Datascope Corp. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0929-06
Company in FDA record
Datascope Corp
FDA classification date
Jun 2, 2006
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

The Anestar and Anestar Plus Anesthesia System may produce periods of high Positive End-Expiratory Pressure (PEEP), in both manual and mechanical ventilation mode due to an issue with the Applied Pressure Limit (APL) valve.

Source facts

Action
Field correction communications were sent 3/17/2006 to all accounts via certified mail, return receipt requested, signature required.
Initiated
2006-03-17
Root cause
Other
Terminated
2006-08-01
Distribution
The units have been distributed to distributors and end-users such as hospitals and clinics nationwide. There are 3 foreign accounts in Australia, El Salvador, and Venezuela.
Recall number
Z-0929-06
Recall status
Terminated
CDRH record ID
45203
FDA classified
2006-06-02
Recall event number
35059

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗